Register now to R3i !
Your Login
Your Password
Confirm Password  
Your Email
The initiative

Prof. Henry Ginsberg

Prof. Henry Ginsberg  
Columbia University,
New York, USA
 
Current position
 
1994 - Irving Professor of Medicine at Columbia University College of Physicians and Surgeons, New York, NY, USA
2006 - Associate Dean for Clinical and Translational Research and Director of the Irving Institute for Clinical and Translational Research at Columbia University Medical Center in New York, NY, USA
 
Past position
 
1978 - 1985 Assistant Professor at the Mount Sinai School of Medicine, New York, NY, USA
1993 - 2001 Head, Division of Preventive Medicine and Nutrution, Columbia University College of Physicians and Surgeons, New York, NY, USA
1994 - 2006 Director General Clinical Research Center, Columbia University College of Physicians and Surgeons, New York, NY, USA
 
Scientific training
 
  MD at the State University of New York Downstate Medical Center in Brooklyn, NY, USA

Training in internal medicine in the Boston University Service of the Boston City Hospital, Boston, MA, USA

Training in endocrinology and metabolism at Stanford University, Palo Alto, CA, USA
 
Professional Associations
 
  Member of the American Diabetes Association
  Fellow of the AHA Council on Arteriosclerosis, Thrombosis and Vascular Biology
  Fellow of the AHA Council on Nutrition, Physical Activity and Metabolism
  Fellow of the American Association for the Advancement of Science
  Member of the American Society for Clinical Investigation
  Member of the Association of American Physicians
  Member of the editorial boards of The Journal of Clinical Investigation, Journal of Lipid Research, and Journal of Metabolism
 
Publications (recent)
 
Research
 
  Principal Investigator of one of the first 12 NIH–funded Clinical Translational Science Awards (CTSA)

Principal investigator on two R01 research grants from the NIH, National Heart, Lung, and Blood Institute

Co-principal investigator at Columbia on the ACCORD Trial
 
His research interests have focused on the regulation of plasma cholesterol and triglyceride blood levels, particularly the metabolism of apolipoprotein B–containing lipoproteins in cells, mice, and humans. Much of his present work focuses on the interaction between insulin resistance and increased secretion of very low-density lipoproteins by the liver. Very active in clinical research training and education, Dr. Ginsberg was also program director of a T32 Postdoctoral Training Grant in Arteriosclerosis for the past 15 years.  The CTSA includes a predoctoral T32 program in translational research, a master’s degree program in patient oriented research, and a junior faculty K12 Clinical Research Scholars Program.